Department of Neurology, Amsterdam UMC, location VUmc.
Department of Neurology, Amsterdam UMC, location VUmc.
Mult Scler Relat Disord. 2022 May;61:103725. doi: 10.1016/j.msard.2022.103725. Epub 2022 Mar 10.
The Arm Function in Multiple Sclerosis Questionnaire (AMSQ) is the first validated disease specific patient-reported outcome measure (PROM) designed to assess upper extremity function in patients with multiple sclerosis (MS).
To determine correlations between the AMSQ and established physician- and performance based outcome measures.
In a cross-sectional cohort of 533 patients correlations between the AMSQ and the Expanded Disability Status Scale (EDSS), its functional systems, the 9-Hole Peg Test (9-HPT) and the Timed-25 Foot Walk (T25FW) were determined. Subgroup analyses were performed as well. Also, correlations were determined in 110 of 533 patients with available longitudinal data.
Strongest correlations were found in the cross-sectional cohort between the AMSQ and the EDSS (β 0.60, p<.001), the 9-HPT dominant hand (β 0.52, p<.001) and 9-HPT non-dominant hand (β 0.46, p<.001), the Pyramidal (β 0.57 p<.001) and the Cerebellar functional system (β 0.54, p<.001) of the EDSS.
The moderate correlations between the AMSQ and several established physician- and performance based outcome measures underline that the AMSQ, an easily at long-distance administrable PROM, could be considered as a reliable outcome measure for the monitoring of MS in daily practice. Additional research is needed to support these findings.
多发性硬化上肢功能问卷(AMSQ)是首个针对多发性硬化症(MS)患者上肢功能评估的经验证的疾病特异性患者报告结局测量工具(PROM)。
确定 AMSQ 与已确立的医生和基于表现的结局测量之间的相关性。
在 533 例患者的横断面队列中,确定了 AMSQ 与扩展残疾状况量表(EDSS)、其功能系统、九孔钉测试(9-HPT)和计时 25 英尺步行测试(T25FW)之间的相关性。还进行了亚组分析。此外,在 533 例有可用纵向数据的患者中,确定了相关性。
在横断面队列中,AMSQ 与 EDSS(β0.60,p<.001)、9-HPT 优势手(β0.52,p<.001)和 9-HPT 非优势手(β0.46,p<.001)、锥体束(β0.57,p<.001)和小脑功能系统(β0.54,p<.001)之间存在最强相关性。
AMSQ 与几个已确立的医生和基于表现的结局测量之间的中度相关性表明,AMSQ 作为一种易于远程管理的 PROM,可以被认为是监测 MS 的可靠结局测量工具。需要进一步的研究来支持这些发现。